Based on clinical tolerance studies, the recommended maximum daily intake is 0.9 g/kg body weight and should be taken in multiple doses
Furthermore, weight loss is likely to remain a concern in non-diabetic patients, particularly if they are already frail or undernourished, and especially in the context of the semaglutide trial, given its enhanced efficacy in promoting weight reduction [39]
The sensation is real and medically documented, not a sign of harm
Ask your doctor for a referral
Sanofi Headquarters: Paris, France Sanofi is kind of a leading healthcare and pharmaceutical company, offering a broad portfolio across diabetes, specialty care, and vaccines